| Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein … AC Bashore, M Liu, CCC Key, E Boudyguina, X Wang, CM Carroll, ... Arteriosclerosis, thrombosis, and vascular biology 39 (9), 1747-1761, 2019 | 32 | 2019 |
| The interaction between sleep and metabolism in Alzheimer’s disease: cause or consequence of disease? CM Carroll, SL Macauley Frontiers in aging neuroscience 11, 258, 2019 | 24 | 2019 |
| KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer’s disease–related pathology J Grizzanti, WR Moritz, MC Pait, M Stanley, SD Kaye, CM Carroll, ... JCI insight 8 (10), 2023 | 12 | 2023 |
| Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF) reveals sex‐dependent changes in microglial EV proteome in response to … MC Pait, SD Kaye, Y Su, A Kumar, S Singh, SC Gironda, S Vincent, ... Journal of Extracellular Vesicles 13 (1), 12398, 2024 | 9 | 2024 |
| Acute hyper-and hypoglycemia uncouples the metabolic cooperation between glucose and lactate to disrupt sleep CM Carroll, M Stanley, RV Raut, NJ Constantino, RE Irmen, A Mitra, ... bioRxiv, 2022.09. 15.507967, 2022 | 4 | 2022 |
| Cortical zeta-inhibitory peptide injection reduces local sleep need CM Carroll, H Hsiang, S Snyder, J Forsberg, MB Dash Sleep 42 (5), zsz028, 2019 | 3 | 2019 |
| Kir6.2-containing KATP channels are necessary for glucose dependent increases in amyloid-beta and Alzheimer’s-related pathology J Grizzanti, WR Moritz, MC Pait, M Stanley, SD Kaye, CM Carroll, ... bioRxiv, 2022.02. 20.481215, 2022 | 2 | 2022 |
| Sulfonylureas target the neurovascular response to decrease Alzheimer’s pathology SL Macauley, MS Stanley, EE Caesar, WR Moritz, AR Bice, N Cruz-Diaz, ... bioRxiv, 2021.08. 11.455969, 2021 | 2 | 2021 |
| Kir6. 2-KATP channels alter glycolytic flux to modulate cortical activity, arousal, and sleep-wake homeostasis NJ Constantino, CM Carroll, HC Williams, CM Yuede, PW Sheehan, ... bioRxiv, 2024.02. 23.581817, 2024 | 1 | 2024 |
| Tau pathology induced alteration in neuronal activity disrupt sleep and cerebral metabolic rhythms in the P301S PS19 mouse model of tauopathy RE Irmen, CM Carroll, NJ Constnantino, JA Snipes, SL Macauley Alzheimer's Association International Conference, 2024 | | 2024 |
| Sleep and Metabolism: Interacting risk factors for Alzheimer’s disease CM Carroll, SL Macauley, RM Benca Alzheimer's Association International Conference, 2024 | | 2024 |
| Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer’s Disease CM Carroll, RM Benca Biomolecules 14 (3), 274, 2024 | | 2024 |
| The role of Kir6. 2‐KATP channels in modulating sleep, brain metabolism, and neuronal excitability in AD NJ Constnantino, CM Carroll, RE Irmen, JA Snipes, RW Gould, ... Alzheimer's & Dementia 19, e075780, 2023 | | 2023 |
| Tau pathology in P301S PS19 mice alters peripheral and cerebral metabolism, sleep, and excitability RE Irmen, CM Carroll, JA Snipes, SA Sink, SL Macauley Alzheimer's & Dementia 19, e074451, 2023 | | 2023 |
| 0085 Peripheral glucose metabolism bidirectionally modulates sleep in a model of Alzheimer's disease C Carroll, N Constantino, R Irmen, JA Snipes, R Benca, S Macauley Sleep 46 (Supplement_1), A38-A39, 2023 | | 2023 |
| Peripheral Metabolic Disruptions Drive Sleep Impairments: Implications for the Pathophysiology of Alzheimer’s Disease CM Carroll Wake Forest University, 2023 | | 2023 |
| Glycemic variability disrupts sleep through KATP channel activity C Carroll, M Stanley, R Irmen, A Mitra, J Snipes, M Raichle, D Holtzman, ... JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 42 (1_ SUPPL), 99-100, 2022 | | 2022 |
| Differential effects of acute hyperglycemia and amyloid‐beta pathology on sleep and cerebral metabolism CM Carroll, M Stanley, C McArdle, A Snipes, R Gould, SL Macauley Alzheimer's & Dementia 17, e053958, 2021 | | 2021 |
| The relationship between disrupted metabolism and sleep is altered by the presence of amyloid-beta pathology CM Carroll, M Stanley, SL Macauley AAIC Neuroscience Next, 2020 | | 2020 |
| Elucidating the link between Alzheimer’s Disease and Type 2 Diabetes: Kir6. 2-/-APP/PS1 exhibit behavioral deficits without an increase in amyloid-beta plaque load LJ Deitelzweig, MC Pait, CM Carroll, CM Yuede, DM Holtzman, ... AAIC Neuroscience Next, 2020 | | 2020 |
